AU4941297A - A method for promoting tissue repair - Google Patents

A method for promoting tissue repair

Info

Publication number
AU4941297A
AU4941297A AU49412/97A AU4941297A AU4941297A AU 4941297 A AU4941297 A AU 4941297A AU 49412/97 A AU49412/97 A AU 49412/97A AU 4941297 A AU4941297 A AU 4941297A AU 4941297 A AU4941297 A AU 4941297A
Authority
AU
Australia
Prior art keywords
tissue repair
promoting tissue
promoting
repair
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49412/97A
Other languages
English (en)
Inventor
Thorsten Jorgensen
Judi Moss
Henrik Vigan Nicolajsen
Lise Sylvest Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xellia Pharmaceuticals ApS
Original Assignee
Dumex Alpharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dumex Alpharma AS filed Critical Dumex Alpharma AS
Publication of AU4941297A publication Critical patent/AU4941297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
AU49412/97A 1996-11-15 1997-11-14 A method for promoting tissue repair Abandoned AU4941297A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK129796 1996-11-15
DK1297/96 1996-11-15
US3544497P 1997-01-30 1997-01-30
US60035444 1997-01-30
PCT/DK1997/000525 WO1998022114A1 (fr) 1996-11-15 1997-11-14 Procede visant a promouvoir la reparation tissulaire

Publications (1)

Publication Number Publication Date
AU4941297A true AU4941297A (en) 1998-06-10

Family

ID=26065547

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49412/97A Abandoned AU4941297A (en) 1996-11-15 1997-11-14 A method for promoting tissue repair

Country Status (2)

Country Link
AU (1) AU4941297A (fr)
WO (1) WO1998022114A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147860A1 (en) 2002-02-07 2003-08-07 Marchosky J. Alexander Compositions and methods for forming and strengthening bone
WO1999062524A1 (fr) * 1998-06-04 1999-12-09 Nutramax Laboratories, Inc. Composition a base d'aminosucre, de glycosaminoglycane et de s-adenosylmethionine pour le traitement et la reparation des tissus conjonctifs
DE19826503A1 (de) 1998-06-13 1999-12-16 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Chitosan und Phospholipiden
FR2791262B1 (fr) 1999-03-22 2001-09-28 Virbac Sa Compositions a base de chondroitine et de chitosan pour la protection, le traitement ou le remplacement des tissus conjonctifs
EP1203074A4 (fr) 1999-06-29 2003-09-10 J Alexander Marchosky Compositions et procede de formation et de renforcement des os
WO2001036000A1 (fr) 1999-11-15 2001-05-25 Bio Syntech Canada, Inc. Solution biopolymere aqueuse auto-gelifiante en fonction du ph et a temperature controlee
AU6888201A (en) 2000-06-29 2002-01-08 Biosyntech Canada Inc Composition and method for the repair and regeneration of cartilage and other tissues
ITMI20012188A1 (it) 2001-10-19 2003-04-19 Interalta S R L Sali d'argento del saccarosio - ottosolfato
US8790688B2 (en) * 2001-12-21 2014-07-29 Coloplast A/S Wound care device for local treatment of pain in a wound
CA2489712C (fr) 2002-06-21 2016-07-12 University Of Utah Research Foundation Composes reticules et leurs procedes de preparation et d'utilisation
US20040019022A1 (en) * 2002-07-25 2004-01-29 Karen Stec Use of 2,3 alkylcarbonyloxybenzoic acids, derivatives and analogues therefrom in the treatment of tissue and cellular dysfunction, damage and injury in mammals
EP2340856B2 (fr) 2003-05-24 2017-11-15 La Prairie Group AG Composition cosmétique ou dérmatologique comprennant une phase d'un milieu nutritif
WO2004110511A1 (fr) * 2003-06-19 2004-12-23 Coloplast A/S Dispositif de soin des plaies
EP1609462B1 (fr) * 2004-04-22 2015-07-29 La Prairie Group AG Préparation cosmétique ou dermatologique comprenant un milieu nutritif
CA2623475A1 (fr) * 2005-09-28 2007-04-05 Dnp Canada Inc. Combinaison de polychitosamine et de fibrate pour prevenir et traiter l'hyperlipidemie
ES2327480B1 (es) * 2007-06-15 2010-08-10 Bioiberica, S.A. "disacaridos para el tratamiento de tendones, ligamentos y huesos".
US20100291055A1 (en) 2007-08-28 2010-11-18 Theodore Athanasiadis Surgical hydrogel
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
WO2012058312A1 (fr) 2010-10-27 2012-05-03 Medtronic, Inc. Agglomérat artificiel destiné à être utilisé dans une voie aérienne
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US10865383B2 (en) 2011-07-12 2020-12-15 Lineage Cell Therapeutics, Inc. Methods and formulations for orthopedic cell therapy
CN102440959B (zh) * 2011-11-29 2013-01-23 海南灵康制药有限公司 一种匹多莫德脂质体固体制剂
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2993182B1 (fr) 2012-07-13 2014-10-17 Urgo Lab Pansement a liberation prolongee d'actifs
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
FR3044555B1 (fr) 2015-12-07 2020-03-06 Centre National De La Recherche Scientifique - Cnrs - Film comprenant un oligosaccharide polysulfate et un polycation et son procede de fabrication
IT201700047632A1 (it) * 2017-05-03 2018-11-03 Ricerfarma Srl Composizioni topiche per mantenere e ripristinare l'omeostasi idrica della pelle
CN114028345B (zh) * 2021-11-18 2023-02-28 海南海灵化学制药有限公司 一种注射用阿扑西林冻干剂及其制备工艺
CN114887121B (zh) * 2022-04-14 2023-04-07 广东粤港澳大湾区国家纳米科技创新研究院 青蒿琥酯-纳米金复合物的胶体液及其制备方法和抗菌产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3937283A1 (de) * 1989-11-09 1991-05-16 Hoechst Ag Polyelektrolytkomplexe zur behandlung und prophylaxe von viruserkrankungen, neue polyelektrolytkomplexe sowie verfahren zu deren herstellung
DE59107006D1 (de) * 1990-04-25 1996-01-18 Hoechst Ag Pharmakologische Zubereitung, enthaltend Polyelektrolytkomplexe in mikropartikulärer Form und mindestens einen Wirkstoff.
JPH04185601A (ja) * 1990-11-20 1992-07-02 Unitika Ltd 白金抗癌剤徐放性製剤
SE518597C2 (sv) * 1994-05-04 2002-10-29 Medicarb Ab Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies

Also Published As

Publication number Publication date
WO1998022114A1 (fr) 1998-05-28

Similar Documents

Publication Publication Date Title
AU4941297A (en) A method for promoting tissue repair
AU1995297A (en) Method for laser surgery
AU4341697A (en) A biometric based method for software distribution
AU9227198A (en) A method for improving skin condition
AU4704397A (en) A brush and method for producing same
EP0904362A4 (fr) Procede de transformation de tissus de plantes
AU7848598A (en) Method for disassembling different elements
SG55308A1 (en) Method for offering a phantom target
AU5252396A (en) Method for preparing a modified solid oxide
EP0821059B8 (fr) Méthode pour transcription inverse
AU6254096A (en) A tissue repair patch
AU4086997A (en) Method for making a diamond-coated member
AU5751298A (en) Method for producing arylcyanates
AU5317398A (en) Method for preparing cyclopropylamines
AU9252198A (en) Method for positioning engraving organs
AU6627698A (en) Method for sterilising a sample
AU2912697A (en) Drive for a generator
AU2183997A (en) New method
AU3814497A (en) Method for immunosuppressing
AU3704297A (en) Method
AU2991497A (en) Method for odor reduction
AU2010097A (en) A method for preparing 3-amino substituted crotonates
AU9013498A (en) Method for a bending procedure
AU5854598A (en) Method for producing 1-phenyl-uracil derivatives
AU2213697A (en) A method for periodontal disease treatment